Identification |
Name: | 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)- |
Synonyms: | 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI);17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol;17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol;17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole;17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole;Anabol;Androstanazol;Androstanazolestanazol;Estazol;Stanazolol;Stromba;Strombaject;Tevabolin;Win 14833;Winstrol; |
CAS: | 10418-03-8 |
EINECS: | 233-894-8 |
Molecular Formula: | C21H32N2O |
Molecular Weight: | 328.49 |
InChI: | InChI=1/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.129 g/cm3 |
Stability: | Stable at normal temperatures and pressures. |
Alpha: | 34 o |
Solubility: | Insoluble |
Appearance: | white to light yellow Powder |
Color: | white to light yellow |
Usage: | Used in the treatment of hereditary angioedema, which causes episodes of swelling of the face, extremities, genitals, bowel wall, and throat. |
Safety Data |
Hazard Symbols |
Xn: Harmful
|
|
|